About uMed
uMed is a company based in London (United Kingdom) founded in 2018 by Matt Wilson.. uMed has raised $17.39 million across 2 funding rounds from investors including Delin Ventures, AlbionVC and Playfair. uMed offers products and services including ACCESS Cohort Studies, AccessPD, AccessCMD, AccessILD, and Recruit. uMed operates in a competitive market with competitors including Carta Healthcare, Verana Health, Clearsense, ClearDATA and Truveta, among others.
- Headquarter London, United Kingdom
- Founders Matt Wilson
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Umedeor Ltd
- Date of Incorporation 16 Nov, 2017
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$17.39 M (USD)
in 2 rounds
-
Latest Funding Round
$12.45 M (USD), Series A
Jul 05, 2023
-
Investors
Delin Ventures
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of uMed
uMed offers a comprehensive portfolio of products and services, including ACCESS Cohort Studies, AccessPD, AccessCMD, AccessILD, and Recruit. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for building and accessing patient cohorts for health studies.
Tool for Parkinson's disease patient data and research insights.
Platform for cardiovascular disease cohort management and analysis.
System for interstitial lung disease patient data collection.
Service for enrolling patients into research studies remotely.
Unlock access to complete
Unlock access to complete
Funding Insights of uMed
uMed has successfully raised a total of $17.39M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $12.45 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $12.5M
-
First Round
First Round
(01 Dec 2020)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2023 | Amount | Series A - uMed | Valuation | Delin Ventures , AlbionVC |
|
| Dec, 2020 | Amount | Seed - uMed | Valuation | AlbionVC , Delin Ventures |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in uMed
uMed has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Delin Ventures, AlbionVC and Playfair. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Delin Ventures is engaged in investing and building companies in life sciences and technology sectors.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on investing in tech startups
|
Founded Year | Domain | Location | |
|
A venture capital firm focused on pre-seed investments in Europe.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by uMed
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - uMed
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Umed Comparisons
Competitors of uMed
uMed operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Carta Healthcare, Verana Health, Clearsense, ClearDATA and Truveta, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
AI-driven clinical data management tools are offered to healthcare providers.
|
|
| domain | founded_year | HQ Location |
Verana Health is focused on real-world data analytics in healthcare.
|
|
| domain | founded_year | HQ Location |
Healthcare analytics platforms and applications are developed for clinicians.
|
|
| domain | founded_year | HQ Location |
Cloud-based clinical data management platform for healthcare providers
|
|
| domain | founded_year | HQ Location |
Healthcare data platform for learning services is provided.
|
|
| domain | founded_year | HQ Location |
Provider of an AI-based medical data management and mining platform for the healthcare industry
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Umed
Frequently Asked Questions about uMed
When was uMed founded?
uMed was founded in 2018 and raised its 1st funding round 2 years after it was founded.
Where is uMed located?
uMed is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Who is the current CEO of uMed?
Matt Wilson is the current CEO of uMed. They have also founded this company.
Is uMed a funded company?
uMed is a funded company, having raised a total of $17.39M across 2 funding rounds to date. The company's 1st funding round was a Seed of $4.94M, raised on Dec 01, 2020.
What does uMed do?
Founded in 2018 in London, United Kingdom, uMed operates in the healthcare technology sector. A collaborative platform is offered for managing clinical data in research and healthcare applications. Precision patient engagement is enabled for research and care programs through healthcare providers. Real-time patient involvement is supported across multiple programs at no extra cost. Research organizations can submit collaboration requests to providers for joint initiatives.
Who are the top competitors of uMed?
uMed's top competitors include Carta Healthcare, Truveta and ClearDATA.
What products or services does uMed offer?
uMed offers ACCESS Cohort Studies, AccessPD, AccessCMD, AccessILD, and Recruit.
Who are uMed's investors?
uMed has 4 investors. Key investors include Delin Ventures, AlbionVC, Playfair, and 11.2 Capital.